|
M Question 1
|
⏱ 0 |
| “Evergreening of patents” involves (a) using small changes in a drug formulation to renew patent protection. (b) compulsory licensing to produce the patented drugs without the consent of the patent owner. (c) extending the duration of patents for a drug through international conventions. (d) giving rights to third party manufacturers for universal production of patented drugs in emergencies. |
|